Boston Scientific Corp. announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating that the TAXUS Express2 paclitaxel-eluting coronary stent system met its primary endpoint in the treatment of in-stent restenosis - the regrowth of diseased tissue into a previously stented artery utilizing bare-metal stents - compared to vascular brachytherapy.


Diagnostic cardiology has experienced revolutionary changes over the past five years as a result of coronary computed tomography angiography (CCTA). The ability to noninvasively obtain three- dimensional anatomic images of technical quality far superior to catheter angiography has forever altered the diagnostic landscape.

Coronary computed tomography angiography (CCTA) has recently made significant technological and clinical advances. Submillimeter slice thickness, increased detectors and reduced acquisition times have multiplied the number of patients that can benefit from noninvasive diagnostic imaging.

The ZOLL R Series is a Code-Ready device that is simple, smart and ready to use. It offers a one step system to simplify and speed up deployment of pacing and defibrillation therapy. It also offers smart tools to help clinicians improve CPR performance, which is important since more than half of in-hospital codes involve non-shockable rhythms and, in such cases, the only treatment is high-quality CPR with minimal interruptions.

Cardiac Science Corp. has launched HeartCentrix, a software solution that enables its diagnostic stress, Holter and electrocardiography devices to communicate seamlessly with physician office-based electronic medical record (EMR) systems.

The ZOLL R Series is a Code-Ready device that is simple, smart and ready to use. It offers a one step system to simplify and speed up deployment of pacing and defibrillation therapy.

The NICO2 Respiratory Profile Monitor is designed to monitor the patient side of the breathing circuit. NICO2 goes beyond conventional capnography to measure breath-by-breath volumetric CO2 and takes the guesswork out of ventilation management from setup to weaning.

The Aplio XG ultrasound system now features new innovations to assist in the diagnosis and treatment of heart failure.

Designed to meet the complex needs of today’s cardiologist, the new comprehensive cardio package features several proprietary innovations for high performance cardiac examinations as well as research and quantification studies.

The Vanguard Dx Angiographic Catheter with patented RadiantFlow tip technology delivers contrast in a unique way. Vanguard Dx produces a “cloud” of contrast rather than a jet stream like traditional catheters. This cloud-like dispersion helps to reduce catheter whipping and enhance tip stability. The catheters are available in the 15 most common shapes and in 4F and 5F sizes.

When used in conjunction with the ev3 embolic protection device, ev3’s PROTÉGÉ RX Carotid Stent has been FDA cleared for the treatment of carotid artery disease in patients who are at high-risk for adverse events from carotid artery surgery. The cleatance was supported by the CREATE (Carotid Revascularization with ev3 Inc.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now